0001209191-23-039157.txt : 20230622 0001209191-23-039157.hdr.sgml : 20230622 20230622183229 ACCESSION NUMBER: 0001209191-23-039157 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230622 DATE AS OF CHANGE: 20230622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wettig Thane CENTRAL INDEX KEY: 0001815638 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 231034498 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0407 4/A 2023-06-07 2023-06-09 0 0000921299 FIBROGEN INC FGEN 0001815638 Wettig Thane C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158 0 1 0 0 Chief Commercial Officer 0 Common Stock 2023-06-07 4 S 0 472 17.0356 D 110338 D Common Stock 2023-06-07 4 S 0 1286 17.0377 D 109052 D Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan. This amendment to Form 4 is being filed solely to correct an inadvertent math error contained in the end of period holdings in Box 5 of the Form 4 filed on June 9, 2023. /s/ Cecelia Monoarfa-Taime, Attorney-in-fact 2023-06-22